Medtronic Adds Smart Insulin Pen By Acquiring Companion Medical

The deal is part of Medtronic's ongoing strategy to revive its diabetes business with technology that simplifies insulin delivery. 

Insulin molecules. Insulin is a protein hormone that regulates the metabolism of carbohydrates and fats. 3d rendering
Insulin Molecules • Source: shutterstock.com

Medtronic plc is adding the InPen “smart” insulin pen to its diabetes portfolio by acquiring Companion Medical for an undisclosed price.

“This acquisition is an ideal strategic fit for Medtronic as we further simplify diabetes management and improve outcomes by optimizing...

More from Business

More from Medtech Insight

Medtech Will Benefit From Boost To EU’s Quantum Technology Initiative

 

The European Commission is focusing on how tiny particles behave to help create an EU industrial “powerhouse.”

Medtronic, Philips Cement New Pact To Embed Next-Gen Tech In Monitoring Platforms

 
• By 

Under the terms of the new agreement, Philips will also begin bundling essential supplies – including ECG, noninvasive blood pressure (NIBP) components, and batteries – with its Medtronic-enabled monitors.

Bivacor Rotary Heart Could Upend The Artificial Heart Market, If It Reaches Its Destination

 
• By 

Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.